Glaxosmithkline Share News (GSK)

MARKET COMMENT: UK Stocks Trade Higher Despite Retail Sales Miss

LONDON (Alliance News) - The FTSE 100 is on track to post its sixth consecutive daily rise Friday, as weaker-than-expected UK retail sales and public finances data failed to dent the recent market positivity. By mid-morning, the FTSE 100 is up 0.4% at 6,836.91, just over 30 points shy of it

UK BROKER RATINGS: JPMorgan Raises View On Home Building Sector

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
UBS RAISES VODAFONE PRICE TARGET TO 275 (260) PENCE - 'BUY'
----------
UBS CUTS SMITHS GROUP TO 'SELL' ('NEUTRAL') -

London open: Stocks at one-month high as Vodafone, RBS gain

- Vodafone, RBS and Glaxo provide a lift - IHG, Glencore Xstrata hit by downgrades - FTSE 100 at highest intraday level in month techMARK 2,891.98 +0.55% FTSE 100 6,840.31 +0.40% FTSE 250 16,419.58 +0.31% Strong gains from heavyweights Vodafone, RBS and GlaxoSmithKline gave UK markets a boost on

UK MORNING BRIEFING: RBS, Glaxo Among The Early Risers

LONDON (Alliance News) - Royal Bank Of Scotland Group is one of the top gainers early Friday on a report that it will shrink dramatically, while GlaxoSmithKline is off to a good start after one of its new drugs was recommended for approval in Europe.

The London equity markets are hi

Glaxo's Incruse Recommended For European Marketing Authorisation

LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that Incruse, a treatment for chronic obstructive pulmonary disease, had been recommended for marketing authorisation by the European Medicines Agency's committee for Medical Products for Human Use, a key step in getting approval for the dr

GSK receives thumbs up from EMA for umeclidinium medicine

GlaxoSmithKline (GSK) said the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for the drugmaker's umeclidinium medicine. The umeclidinium, under the proposed brand name Incruse, is a once-daily treatment to relieve s

UPDATE 1-GSK receives European nod for COPD drugs Anoro, Incruse

LONDON, Feb 20 (Reuters) - Anoro, a combination drug for chronic obstructive pulmonary disease (COPD) developed by GlaxoSmithKline and Theravance, has received the green light from European regulators, the companies said on Thursday. The medicine is a combination of umeclidinium, a long-act

GlaxoSmithKline's COPD drug Anoro receives European green light

LONDON, Feb 20 (Reuters) - Anoro, a combination drug for chronic obstructive pulmonary disease (COPD) developed by GlaxoSmithKline and Theravance, has received the green light from European regulators, the companies said on Thursday. The drug is a combination of UMEC, a long-acting muscarin

Glaxo's Anoro For Treatment Of COPD Recommended For Marketing Authorisation

LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday that its treatment for chronic obstructive pulmonary disease Anoro had been recommended for marketing authorisation from the European Medicines Agency's committee for Medical Products for Human Use. Glaxo expects a final decision on

Indian stocks to watch - Feb 20

GLOBAL MARKETS ROUNDUP * Nifty futures on the Singapore Exchange are down 0.66 percent, while the MSCI-Asia Pacific excluding Japan index was lower 0.95 percent. * Asian stocks languished in early trade on Thursday and the dollar firmed, after minutes of the Federal Reserve's latest policy meeti

MARKET COMMENT: UK Stocks Lose Momentum Ahead Of FOMC Minutes

LONDON (Alliance News) - UK stocks have struggled to get off the ground Wednesday, closing broadly unchanged despite some impressive individual stock performances. The FTSE 100 initially opened higher, continuing a rally that has seen the index retrace most of January's losses. However, after bre

FTSE 100 movers: Sports Direct jumps after strong update

Sports Direct International shot to the top of the risers after group sales in the quarter to January 26th rose 11.2 per cent from the previous year to 655.4m pounds. Gross profit gained 14.6 per cent to 280.7m pounds during the period with growth across all its divisions including Sports Retail, Br

London midday: Stocks slip after surprise increase in jobless rate

- UK jobless rate rises to 7.2 per cent, above estimates - MPC votes unanimously to leave policy unchanged - Ex-div stocks provide a drag on FTSE - Sports Direct jumps after Q3 update techMARK 2,855.22 -0.93% FTSE 100 6,761.33 -0.52% FTSE 250 16,233.58 -0.66% UK markets pulled back from a four-w

London open: Stocks pause at four-week high ahead of data, BoE minutes

- Markets at highest since January 22nd - UK labour-market data due out, BoE minutes - Sports Direct, M&S, BAE Systems lead the upside - Ex-div stocks weigh techMARK 2,878.02 -0.14% FTSE 100 6,798.45 +0.03% FTSE 250 16,340.79 -0.01% UK stocks opened more or less flat on Wednesday morning after th

UK Dividends Calendar - Week Ahead